HK1123507A1 - Composition for preventing or treating damages of the mucosa in the gastrointestinal tracts - Google Patents

Composition for preventing or treating damages of the mucosa in the gastrointestinal tracts

Info

Publication number
HK1123507A1
HK1123507A1 HK09101447.8A HK09101447A HK1123507A1 HK 1123507 A1 HK1123507 A1 HK 1123507A1 HK 09101447 A HK09101447 A HK 09101447A HK 1123507 A1 HK1123507 A1 HK 1123507A1
Authority
HK
Hong Kong
Prior art keywords
mucosa
preventing
composition
gastrointestinal tracts
treating damages
Prior art date
Application number
HK09101447.8A
Other languages
English (en)
Inventor
Ki-Baik Hahm
Dong-Kyu Kim
Mi-Sun Kwak
Sang-Aun Joo
Byoung-Seok Moon
Geun-Seog Song
Original Assignee
Yuhan Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuhan Corp filed Critical Yuhan Corp
Publication of HK1123507A1 publication Critical patent/HK1123507A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK09101447.8A 2005-12-01 2009-02-16 Composition for preventing or treating damages of the mucosa in the gastrointestinal tracts HK1123507A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20050116567 2005-12-01
PCT/KR2006/005044 WO2007064128A1 (en) 2005-12-01 2006-11-28 Composition for preventing or treating damages of the mucosa in the gastrointestinal tracts

Publications (1)

Publication Number Publication Date
HK1123507A1 true HK1123507A1 (en) 2009-06-19

Family

ID=38092428

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09101447.8A HK1123507A1 (en) 2005-12-01 2009-02-16 Composition for preventing or treating damages of the mucosa in the gastrointestinal tracts

Country Status (15)

Country Link
US (1) US7776873B2 (pt)
EP (1) EP1954279A4 (pt)
JP (1) JP5207974B2 (pt)
KR (1) KR100805660B1 (pt)
CN (2) CN102309490A (pt)
AU (1) AU2006321471B2 (pt)
BR (1) BRPI0619081A2 (pt)
CA (1) CA2631068C (pt)
CR (1) CR10018A (pt)
EC (1) ECSP088545A (pt)
HK (1) HK1123507A1 (pt)
IL (1) IL191680A0 (pt)
MY (1) MY145406A (pt)
WO (1) WO2007064128A1 (pt)
ZA (1) ZA200805747B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2673536A1 (en) * 2006-12-22 2008-07-03 Yuhan Corporation Revaprazan-containing solid dispersion and process for the preparation thereof
CN102470126A (zh) 2009-07-09 2012-05-23 拉夸里亚创药株式会社 用于治疗与异常肠胃运动有关的疾病的酸泵拮抗剂
KR101730865B1 (ko) * 2011-02-11 2017-04-27 주식회사유한양행 레바프라잔-함유 나노입자를 포함하는 경구투여용 약학 조성물 및 그의 제조방법
KR101739818B1 (ko) * 2011-05-20 2017-05-26 주식회사유한양행 레바프라잔 또는 그의 염을 함유하는 현탁액 형태의 경구투여용 약학 조성물
TWI710379B (zh) 2015-07-30 2020-11-21 日商武田藥品工業股份有限公司 錠劑
CN105998688A (zh) * 2016-06-22 2016-10-12 郑亮 一种胃粘膜损伤的抑制方法
KR20180107341A (ko) * 2017-03-16 2018-10-02 차의과학대학교 산학협력단 칼륨 경쟁적 위산분비억제제를 유효성분을 함유하는 장 누수 증후군 치료 및 예방용 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ235877A (en) * 1989-11-02 1992-09-25 Mcneil Ppc Inc Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
ES2201112T3 (es) * 1994-08-13 2004-03-16 Yuhan Corporation Nuevos derivados de pirimidina y procedimientos para su preparacion.
CA2358479C (en) * 1996-05-04 2004-07-13 Yuhan Corporation 4-substituted-2-(4-fluorophenylamino)-5,6 dimethylpyrimidine
KR20000052775A (ko) * 1996-10-25 2000-08-25 가마쿠라 아키오 신규한 헤테로사이클릭 아미드 화합물 및 의약으로서의 그의 용도
HU226752B1 (en) 1996-10-29 2009-09-28 Yuhan Corp Process for preparation of pyrimidine derivatives
GB0110338D0 (en) * 2001-04-27 2001-06-20 Sb Pharmco Inc Novel processes
US8206741B2 (en) * 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs

Also Published As

Publication number Publication date
WO2007064128A1 (en) 2007-06-07
CN101316594B (zh) 2012-07-25
BRPI0619081A2 (pt) 2011-09-20
JP2009517462A (ja) 2009-04-30
JP5207974B2 (ja) 2013-06-12
KR100805660B1 (ko) 2008-02-21
US7776873B2 (en) 2010-08-17
EP1954279A1 (en) 2008-08-13
CA2631068A1 (en) 2007-06-07
ZA200805747B (en) 2009-11-25
AU2006321471B2 (en) 2010-07-29
US20070129391A1 (en) 2007-06-07
MY145406A (en) 2012-02-15
AU2006321471A1 (en) 2007-06-07
ECSP088545A (es) 2008-08-29
EP1954279A4 (en) 2009-06-03
KR20070057663A (ko) 2007-06-07
CN101316594A (zh) 2008-12-03
IL191680A0 (en) 2009-08-03
CA2631068C (en) 2011-01-11
CN102309490A (zh) 2012-01-11
CR10018A (pt) 2008-09-02

Similar Documents

Publication Publication Date Title
EP1853295A4 (en) METHOD AND COMPOSITIONS FOR TREATING GASTROINTESTINAL DISEASES
EP1940441A4 (en) COMPOSITIONS AND METHODS FOR TREATING GASTROINTESTINAL DISORDERS
ZA200904492B (en) Compositions and methods for the treatment of infections and tumors
EP1899480A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY CONDITIONS
IL185056A0 (en) Compositions and methods for treating or preventing flaviviridae infections
EP1959929A4 (en) COMPOSITIONS AND METHODS FOR TREATING DERMATOLOGICAL SUFFERING
CA2645871A1 (en) PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OXALATE-ASSOCIATED DISEASE
ZA200709745B (en) Compositions and methods for inhibiting gastric acid secretion
IL185396A0 (en) Methods of treating gastrointestinal inflammation
SI1937262T1 (sl) Spojina za uporabo pri zdravljenju gastrointestinalne dismotilitete
ZA200708575B (en) Methods and compositions for treating or preventing cancer
HK1121952A1 (en) Methods and compositions for treating conditions
PL2529626T3 (pl) Kompozycje i sposoby leczenia lub zapobiegania nowotworowi okrężnicy
EP1996218A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
IL191537A0 (en) Methods and compositions for the treatment of gastrointestinal disorders
ZA200800448B (en) Methods and compositions for the prevention and treatment of inflammatory disease
HK1123507A1 (en) Composition for preventing or treating damages of the mucosa in the gastrointestinal tracts
EP1909809A4 (en) METHOD AND COMPOSITION FOR TREATING DIABETES AND ITS COMPLICATIONS
PL2056799T3 (pl) Kompozycje i sposoby do leczenia lub zapobiegania jaskrze lub jej rozwojowi
ZA200707955B (en) Methods and pharmaceutical compositions for the treatment of neurological damage
EP1904088A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANCER
EP1782788A4 (en) REDUCTION COMPOSITION FOR CONTINUOUS WAVING TREATMENT OR JUST PERMANENT WAVY TREATMENT
IL185136A0 (en) Oral compositions for the prevention of uv damages
HK1096609A1 (en) Pharmaceutical composition for treating gastric disease containing antiulcerent and mucosal protective agents
HU0500947D0 (en) Composition for treatment of paradontosis